company background image
ACT logo

AlzChem Group DB:ACT Stock Report

Last Price

€58.40

Market Cap

€586.2m

7D

-0.3%

1Y

137.4%

Updated

18 Dec, 2024

Data

Company Financials +

AlzChem Group AG

DB:ACT Stock Report

Market Cap: €586.2m

ACT Stock Overview

Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

ACT fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance6/6
Financial Health6/6
Dividends3/6

Rewards

Trading at 72.4% below our estimate of its fair value

Earnings are forecast to grow 12.82% per year

Earnings grew by 65.3% over the past year

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 28.8%

Risk Analysis

Unstable dividend track record

Volatile share price over the past 3 months compared to the German market


My Notes

Capture your thoughts, links and company narrative

AlzChem Group AG Competitors

Uzin Utz

XTRA:UZU

€245.2m

H&R GmbH KGaA

XTRA:2HRA

€125.4m

Nabaltec

XTRA:NTG

€124.5m

Wacker Chemie

XTRA:WCH

€3.4b

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price€58.40
52 Week High€64.80
52 Week Low€22.40
Beta0.96
1 Month Change1.74%
3 Month Change41.40%
1 Year Change137.40%
3 Year Change150.64%
5 Year Change189.11%
Change since IPO117.18%

Recent News & Updates

Recent updates

Shareholder Returns

ACTDE ChemicalsDE Market
7D-0.3%-2.9%-1.1%
1Y137.4%-7.2%8.1%

Return vs Industry: ACT exceeded the German Chemicals industry which returned -7.2% over the past year.

Return vs Market: ACT exceeded the German Market which returned 8.1% over the past year.

Price Volatility

Is ACT's price volatile compared to industry and market?
ACT volatility
ACT Average Weekly Movement7.5%
Chemicals Industry Average Movement4.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.8%
10% least volatile stocks in DE Market2.5%

Stable Share Price: ACT's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: ACT's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
19081,607Andreas Niedermaierwww.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACT fundamental statistics
Market cap€586.16m
Earnings (TTM)€50.10m
Revenue (TTM)€563.55m

11.7x

P/E Ratio

1.0x

P/S Ratio

Is ACT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACT income statement (TTM)
Revenue€563.55m
Cost of Revenue€214.74m
Gross Profit€348.81m
Other Expenses€298.71m
Earnings€50.10m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 28, 2025

Earnings per share (EPS)4.92
Gross Margin61.90%
Net Profit Margin8.89%
Debt/Equity Ratio0%

How did ACT perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 01:50
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AlzChem Group AG is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Laura Lopez PinedaBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Knut WollerBaader Helvea Equity Research